AU3628093A - Parathyroid hormone fragments, their preparation and medicaments containing the same - Google Patents
Parathyroid hormone fragments, their preparation and medicaments containing the sameInfo
- Publication number
- AU3628093A AU3628093A AU36280/93A AU3628093A AU3628093A AU 3628093 A AU3628093 A AU 3628093A AU 36280/93 A AU36280/93 A AU 36280/93A AU 3628093 A AU3628093 A AU 3628093A AU 3628093 A AU3628093 A AU 3628093A
- Authority
- AU
- Australia
- Prior art keywords
- fragments
- pct
- preparation
- medicaments containing
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012634 fragment Substances 0.000 title abstract 6
- 102000003982 Parathyroid hormone Human genes 0.000 title abstract 4
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 4
- 239000000199 parathyroid hormone Substances 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 229960001319 parathyroid hormone Drugs 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
PCT No. PCT/EP93/00259 Sec. 371 Date Jul. 20, 1994 Sec. 102(e) Date Jul. 20, 1994 PCT Filed Feb. 4, 1993 PCT Pub. No. WO93/15109 PCT Pub. Date Aug. 5, 1993The invention concerns parathormone (PTH) fragments including the amino acid range of the natural parathormone of +3 to +35 and their physiologically compatible derivatives, a process for the preparation of the fragments according to the solid phase and liquid phase synthesis from partly blocked amino acids contained in the fragments which are coupled with one another in the sequence which corresponds to the amino acid sequence in the fragments to be prepared and medicaments containing at least one of the fragments, especially with calcium-regulating action in the body.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4203040A DE4203040A1 (en) | 1992-02-04 | 1992-02-04 | NEW PARATHORMON FRAGMENTS, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM |
| DE4203040 | 1992-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3628093A true AU3628093A (en) | 1993-09-01 |
Family
ID=6450869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU36280/93A Abandoned AU3628093A (en) | 1992-02-04 | 1993-02-04 | Parathyroid hormone fragments, their preparation and medicaments containing the same |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5783558A (en) |
| EP (1) | EP0625163B1 (en) |
| JP (1) | JPH07507051A (en) |
| KR (1) | KR950700326A (en) |
| AT (1) | ATE171952T1 (en) |
| AU (1) | AU3628093A (en) |
| CA (1) | CA2126974A1 (en) |
| DE (2) | DE4203040A1 (en) |
| HU (1) | HUT69708A (en) |
| IL (1) | IL104580A (en) |
| MX (1) | MX9300586A (en) |
| TW (1) | TW286320B (en) |
| WO (1) | WO1993015109A2 (en) |
| ZA (1) | ZA93727B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08503692A (en) * | 1992-08-05 | 1996-04-23 | アール． ヒリカー，サンドラ | Parathyroid hormone fragments and analogs |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| DE19538687A1 (en) * | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stable pharmaceutical dosage forms containing parathyroid hormone |
| ES2302374T3 (en) | 1998-05-05 | 2008-07-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | PTH2 RECEPTORS SELECTIVE COMPOUND. |
| US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
| US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
| US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
| WO2004028444A2 (en) * | 1999-06-02 | 2004-04-08 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
| EP1531855A4 (en) | 2002-01-10 | 2009-07-22 | Osteotrophin Llc | Treatment of bone disorders with skeletal anabolic drugs |
| US20040067526A1 (en) * | 2002-10-03 | 2004-04-08 | Cantor Thomas L. | Methods for diagnosing and guiding treatment of bone turnover disease |
| KR100540659B1 (en) * | 2003-07-02 | 2006-01-10 | 삼성전자주식회사 | Method and apparatus for printing enlarged image, and computer-readable recording media for storing computer program |
| US7541140B2 (en) * | 2004-06-03 | 2009-06-02 | Scantibodies Laboratory, Inc. | Assessing risk for kidney stones using parathyroid hormone agonist and antagonist |
| JP2009515535A (en) * | 2005-11-10 | 2009-04-16 | ボード オブ コントロール オブ ミシガン テクノロジカル ユニヴァーシティー | Methods of using black bear parathyroid hormone and black bear parathyroid hormone |
| EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| CN108066740A (en) * | 2016-11-07 | 2018-05-25 | 亿菩升（上海）生物科技有限公司 | Application of the ox bone peptide in the drug and food that treat and prevent osteoporosis is prepared |
| CN111057139B (en) * | 2018-10-17 | 2023-12-22 | 南京华威医药科技集团有限公司 | Novel process for preparing teriparatide |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4086196A (en) * | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
| US4423037A (en) * | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
| US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
| US5457092A (en) * | 1987-07-30 | 1995-10-10 | Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) | Methods of promoting bone growth in mammals comprising administration of modified parathyroid hormone |
| DE3725320A1 (en) * | 1987-07-30 | 1989-02-09 | Biotechnolog Forschung Gmbh | EXPRESSION VECTORS AND METHOD THEREFORE FOR THE EXTRACTION OF CRO / SS GALACTOSIDASE / PTH FUSION PROTEINS AND OF PTH |
| DE3935738A1 (en) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | DRUGS CONTAINING THE HUMAN PARATHORMONE FRAGMENT (1-37) AS AN ACTIVE AGENT |
| JP2952951B2 (en) * | 1990-04-12 | 1999-09-27 | 三菱化学株式会社 | Peptide derivative |
| GB9020544D0 (en) * | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
| JPH0532696A (en) * | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | Parathyroid hormone derivative |
| US5434246A (en) * | 1992-03-19 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Parathyroid hormone derivatives |
| US5358934A (en) * | 1992-12-11 | 1994-10-25 | The United States Of America As Represented By The Secretary Of Agriculture | Materials and methods for control of pests |
-
1992
- 1992-02-04 DE DE4203040A patent/DE4203040A1/en not_active Ceased
-
1993
- 1993-01-28 TW TW082100486A patent/TW286320B/zh active
- 1993-02-01 IL IL10458093A patent/IL104580A/en not_active IP Right Cessation
- 1993-02-03 ZA ZA93727A patent/ZA93727B/en unknown
- 1993-02-03 MX MX9300586A patent/MX9300586A/en unknown
- 1993-02-04 US US08/256,363 patent/US5783558A/en not_active Expired - Fee Related
- 1993-02-04 EP EP93905233A patent/EP0625163B1/en not_active Expired - Lifetime
- 1993-02-04 AT AT93905233T patent/ATE171952T1/en not_active IP Right Cessation
- 1993-02-04 JP JP5512945A patent/JPH07507051A/en active Pending
- 1993-02-04 CA CA002126974A patent/CA2126974A1/en not_active Abandoned
- 1993-02-04 WO PCT/EP1993/000259 patent/WO1993015109A2/en active IP Right Grant
- 1993-02-04 DE DE59309044T patent/DE59309044D1/en not_active Expired - Fee Related
- 1993-02-04 HU HU9402272A patent/HUT69708A/en active IP Right Revival
- 1993-02-04 AU AU36280/93A patent/AU3628093A/en not_active Abandoned
-
1994
- 1994-08-04 KR KR1019940702726A patent/KR950700326A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US5783558A (en) | 1998-07-21 |
| ZA93727B (en) | 1994-08-03 |
| WO1993015109A2 (en) | 1993-08-05 |
| MX9300586A (en) | 1993-08-01 |
| KR950700326A (en) | 1995-01-16 |
| CA2126974A1 (en) | 1993-08-05 |
| IL104580A0 (en) | 1993-06-10 |
| HU9402272D0 (en) | 1994-11-28 |
| EP0625163B1 (en) | 1998-10-07 |
| IL104580A (en) | 1997-01-10 |
| DE4203040A1 (en) | 1993-08-05 |
| ATE171952T1 (en) | 1998-10-15 |
| HUT69708A (en) | 1995-09-28 |
| JPH07507051A (en) | 1995-08-03 |
| DE59309044D1 (en) | 1998-11-12 |
| WO1993015109A3 (en) | 1993-08-19 |
| EP0625163A1 (en) | 1994-11-23 |
| TW286320B (en) | 1996-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1993015109A3 (en) | Parathyroid hormone fragments, their preparation and medicaments containing the same | |
| IL112112A0 (en) | Peptide derivatives and pharmaceutical compositions containing them | |
| AU4835396A (en) | Composition containing nucleic acids, preparation and use | |
| GB2364304A (en) | Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them | |
| AU2624400A (en) | Monodisperse hexameric acylated insulin analog formulations | |
| AU3173297A (en) | Exendin analogues, processes for their preparation and medicaments containing them | |
| ATE311196T1 (en) | COMPOSITIONS SUITABLE FOR THE CONTROLLED RELEASE OF THE HORMONE GNRH AND ITS ANALOGUES | |
| WO1994012219A3 (en) | Modified insulin-like growth factors | |
| EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| HU9501719D0 (en) | Polypeptide and anti-hiv agent prepared therefrom | |
| AU7217096A (en) | Stabilised pharmaceutical preparations containing thyroid hormone | |
| HUP0002392A3 (en) | Diazole and oxazole derivatives as growth hormone secretagogues, process for producing them and pharmaceutical compositions containing them | |
| AU2705588A (en) | New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use. | |
| AU1381697A (en) | Method for preparation of active substances from nacre, resulting products, useful in medicinal applications | |
| IL113178A (en) | 8alpha-3-hydroxyestra-1,3,5(11)tetraen-17-one( 9(11)-dehydro-8-isoestrone) its preparation and pharmaceutical composition containing it | |
| CA2303395A1 (en) | Treatment of obesity | |
| GR3031789T3 (en) | Novel colon- or ileum-specific steroid derivatives. | |
| EP0173664A3 (en) | Biologically active benzimidazole compounds and process for their preparation | |
| GR3031687T3 (en) | Hgh containing pharmaceutical compositions | |
| EP0286441A3 (en) | Novel cytotoxic protein | |
| CA2130333A1 (en) | Process for preparing .beta.-phenylisoserine and analogues thereof | |
| IN172427B (en) | ||
| HUT51221A (en) | Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients | |
| AU3364289A (en) | Process for the preparation of 5-membered nitrogen-containingheteroaromatics | |
| EP0373613A3 (en) | Pyridine-3-percarboxylic acid monopersulfate |